A practical guide about biosimilar data for health care providers treating inflammatory diseases

To make informed decisions about the safety, efficacy, and clinical utility of a biosimilar, health care providers should understand the types and be able to analyze data generated from a biosimilar development program. This article reviews the biosimilar guidelines, the biosimilar development proce...

Descripción completa

Detalles Bibliográficos
Autores principales: Markenson, Joseph, Alvarez, Daniel F, Jacobs, Ira, Kirchhoff, Carol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338847/
https://www.ncbi.nlm.nih.gov/pubmed/28280299
http://dx.doi.org/10.2147/BTT.S122335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338847/
https://www.ncbi.nlm.nih.gov/pubmed/28280299
http://dx.doi.org/10.2147/BTT.S122335

Ejemplares similares